Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide

EU orphan designation number: EU/3/07/478   
Active ingredient: N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide
Indication: Treatment of Hodgkin lymphoma
Sponsor: ICON Clinical Research Limited
South County Business Park, Leopardstown, Dublin 18 Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Orphan designation EMEA/OD/053/07 (2007)4328 of 14/09/2007
6/11/2008 Transfer of orphan designation EMEA/OD/053/07/T/01 (2008)6721 of 4/11/2008
27/03/2009 Transfer of orphan designation EMEA/OD/053/07/T/02 (2009)2320 of 25/03/2009
18/11/2015 Change of name and/or address of sponsor
6/02/2018 Transfer of orphan designation EMA/OD/053/07/T/03 (2018)697 of 1/02/2018